Abstract
The emergence of antimicrobial resistance among clinically relevant bacteria has resulted in profound changes in the approach to treatment of infections caused by these pathogens. This chapter will focus on three epidemiologically important gram-positive bacteria: Streptococcus pneumoniae, Staphylococcus aureus, and Enterococcus species. Common infections due to these organisms, common resistance mechanisms, and available treatment options will be reviewed.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Lee C, Banks SD, Li JP (1999). Virulence, immunity and vaccine related Streptococcus pneumoniae. Crit Rev Microbiol 18:89–114
Ekdahl K, Ahlinder I, Hansson HB et al. (1997). Duration of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae: Experiences from South Swedish Pneumococcal Intervention Project. Clin Infect Dis 25:1113–1117
Fedson DS, Musher DM (2003). Pneumococcal vaccine. In: Plotkin SA, Orenstein WB (eds) Vaccines. Philadelphia: WB Saunders
Whitney CG, Farley MM, Hadler J, Harrison LH (2003). Decline in invasive pneumococcal disease after the Introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348:1737–1746
Whitney CG, Farley MM, Hadler J et al. (2000). Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 343:1917–1924
Doern GV, Richter SS, Miller A et al. (2005). Antimicrobial resistance among Streptococcus pneumoniae in the United States: Have we begun to turn the corner on resistance to certain antimicrobial classes? Clin Infect Dis 41:139–148
Waterer GW, Somes GW, Wunderink RG (2001). Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Intern Med 161:1837–1842
Francis JS, Lopatin U et al. (2005). Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton Valentine leukocidin genes. Clin Infect Dis 40:100–107
National Nosocomial Infection Surveillance (NNIS) System (2004). National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32:470–485
Cosgrove SE, Sakoulas G, Perencevich EN et al. (2003). Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis. Clin Infect Dis 36:53–59
Engemann JJ, Carmeli Y, Cosgrove SE et al. (2003). Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 36:592–598
Fridkin SK, Hageman JC, Morrison M et al. (2005). Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 352:1436–1444
Moran GJ, Krishnadasan A, Gorwitz RJ et al. (2006). Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 355:666–674
Klevens RM, Morrison MA, Nadle J et al. (2007). Invasive methicillin-resistant Staphylococcus aureus infections in the United States. J Am Med Assoc 298:1763–1771
Sharpe JN, Shively EH, Polk HC, Jr. (2005). Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. Am J Surg 189(4):425–428
Kollef MH, Rello J, Cammarata SK et al. (2004). Clinical cure and survival in gram-positive ventilator-associated pneumonia: Retrospective analysis of two double-blind studies comparing linezolid with vancomycin. Intensive Care Med 30(3):388–394
Rice LB (2006). Antimicrobial resistance in gram-positive bacteria. Am J Med 119:S11–S19
Sievert DM, Rudrik JT, Patel JB et al. (2008). Vancomycin-resistant Staphylococcus aureus in the United States, 2002–2006. Clin Infect Dis 46:668–674
Murray BE (2000). Vancomycin-resistant enterococcal infections. N Engl J Med 342:710–721
Carmeli Y et al. (2002). Health and economic outcomes of vancomycin-resistant enterococci. Arch Intern Med 162:2223–2238
Salgado CD, Farr BM (2003). Outcomes associated with vancomycin-resistant enterococci: A meta-analysis. Infect Control Hosp Epidemiol 24:690–698
Moellering RC (2003). Linezolid: The first oxazolidinone antimicrobial. Ann Intern Med 138:135–142
Bradford PA (2004). Tigecycline: A first in class glycylcycline. Clin Microbiol Newsl 26:163–168
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Salgado, C.D. (2010). Antimicrobial Resistance Among Epidemiologically Important Gram-Positive Bacteria. In: Mainous III, A., Pomeroy, C. (eds) Management of Antimicrobials in Infectious Diseases. Infectious Disease. Humana Press. https://doi.org/10.1007/978-1-60327-239-1_2
Download citation
DOI: https://doi.org/10.1007/978-1-60327-239-1_2
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-238-4
Online ISBN: 978-1-60327-239-1
eBook Packages: MedicineMedicine (R0)